CoreWeave (CRWV) CDO-linked trusts sell 53K shares and convert 52.5K via derivatives
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
CoreWeave, Inc. Chief Development Officer Brannin McBee reported indirect transactions in Class A and Class B Common Stock through several family trusts and grantor retained annuity trusts. Entities associated with McBee made open-market sales totaling 53,000 shares of Class A Common Stock at prices generally in the mid‑$80s per share, with footnotes noting ranges from $82.62 to $87.51 and indicating at least some sales were executed under a Rule 10b5-1 trading plan adopted on March 5, 2026.
On the same date, indirect holdings also acquired 52,500 shares via derivative conversions coded "C" at a stated price of $0.00 per share, including 12,500 shares for Canis Minor 2025 GRAT and 40,000 shares for Canis Major 2025 GRAT. Footnotes explain that each share of Class B Common Stock is convertible into one share of Class A Common Stock and that the reported securities are held by various GRATs, family trusts, and a minor-child trust for which McBee or family members serve as trustee, beneficiary, or manager.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 53,000 shares ($4,564,858)
Net Sell
24 txns
Insider
McBee Brannin
Role
Chief Development Officer
Sold
53,000 shs ($4.56M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Conversion | Class B Common Stock | 40,000 | $0.00 | -- |
| Conversion | Class B Common Stock | 12,500 | $0.00 | -- |
| Conversion | Class A Common Stock | 40,000 | $0.00 | -- |
| Sale | Class A Common Stock | 1,896 | $83.0883 | $158K |
| Sale | Class A Common Stock | 544 | $84.3142 | $46K |
| Sale | Class A Common Stock | 8,842 | $85.7496 | $758K |
| Sale | Class A Common Stock | 25,566 | $86.4038 | $2.21M |
| Sale | Class A Common Stock | 3,152 | $87.1126 | $275K |
| Conversion | Class A Common Stock | 12,500 | $0.00 | -- |
| Sale | Class A Common Stock | 593 | $83.0882 | $49K |
| Sale | Class A Common Stock | 170 | $84.3149 | $14K |
| Sale | Class A Common Stock | 2,763 | $85.7496 | $237K |
| Sale | Class A Common Stock | 7,989 | $86.4038 | $690K |
| Sale | Class A Common Stock | 985 | $87.1127 | $86K |
| Sale | Class A Common Stock | 24 | $83.0733 | $2K |
| Sale | Class A Common Stock | 7 | $84.29 | $590.03 |
| Sale | Class A Common Stock | 111 | $85.7508 | $10K |
| Sale | Class A Common Stock | 319 | $86.4045 | $28K |
| Sale | Class A Common Stock | 39 | $87.1087 | $3K |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
Holdings After Transaction:
Class B Common Stock — 3,717,227 shares (Indirect, Canis Major 2025 GRAT);
Class A Common Stock — 40,000 shares (Indirect, Canis Major 2025 GRAT)
Footnotes (1)
- Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary. The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.62 to $83.52, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.92 to $84.91, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.96 to $85.95, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.96 to $86.95, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.96 to $87.51, inclusive. The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee. The reported securities are directly held by the Canis Major SM Trust (the "Canis Trust"), an irrevocable trust with a third-party trustee, of which the reporting person's minor child is beneficiary. The reporting person has the power to remove and replace the Canis Trust's trustee. The reported securities are directly held of record by the reporting person's child. The reported securities are directly held by the Canis Major 2025 Family Trust LLC, of which the reporting person serves as manager. The reported securities are directly held by the Canis Minor 2025 Family Trust LLC, of which the reporting person serves as manager.
Key Figures
Net shares sold: 53,000 shares
Shares acquired via conversion: 52,500 shares
Sale price range: $82.62–$87.51 per share
+3 more
6 metrics
Net shares sold
53,000 shares
Net open-market sales of Class A Common Stock on July 6, 2026
Shares acquired via conversion
52,500 shares
Class A Common Stock from derivative conversions coded “C”
Sale price range
$82.62–$87.51 per share
Price ranges for multiple sale transactions noted in footnotes
Canis Minor 2025 GRAT Class B underlying
498,705 underlying shares
Class B Common Stock convertible into Class A, indirect holding
Canis Major 2025 GRAT Class B underlying
3,717,227 underlying shares
Class B Common Stock convertible into Class A, indirect holding
Rule 10b5-1 plan adoption date
March 5, 2026
Referenced for at least one reported sale transaction
Key Terms
Rule 10b5-1 trading plan, grantor retained annuity trust, Class B Common Stock, derivative conversion, +1 more
5 terms
Rule 10b5-1 trading plan financial
"sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
grantor retained annuity trust financial
"reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary"
A grantor retained annuity trust (GRAT) is an estate-planning tool where the person who creates the trust transfers assets into it but receives fixed cash payments (an annuity) from the trust for a set number of years; whatever remains after that term passes to designated beneficiaries. It matters to investors because it can shift future appreciation of assets out of the creator’s taxable estate—like putting an asset into a timed vending machine that pays you fixed amounts while any extra value that grows inside the machine goes to heirs with reduced gift or estate tax consequences.
Class B Common Stock financial
"Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock"
A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.
derivative conversion financial
"transaction_code_description: Conversion of derivative security"
indirect ownership financial
"ownership_type: indirect, nature_of_ownership: Canis Minor 2025 Family Trust LLC"
FAQ
What insider transactions did CoreWeave (CRWV) report for Brannin McBee?
CoreWeave reported that entities associated with Chief Development Officer Brannin McBee executed open-market sales of Class A Common Stock and derivative conversions on July 6, 2026. The transactions occurred through several family trusts and grantor retained annuity trusts holding indirect interests.
Were any of the CoreWeave (CRWV) insider sales under a Rule 10b5-1 plan?
Yes. A footnote states that at least one reported sale was effected under a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026. Such plans pre-schedule trades, making their timing less discretionary for the insider.
What derivative conversions did the CoreWeave (CRWV) Form 4 disclose?
The Form 4 reports derivative conversions coded “C” totaling 52,500 shares of Class A Common Stock at a stated price of $0.00 per share. These include 12,500 shares for Canis Minor 2025 GRAT and 40,000 shares for Canis Major 2025 GRAT.
How are Brannin McBee’s CoreWeave (CRWV) holdings structured after these transactions?
Post-transaction, the filing shows indirect holdings through multiple entities, including Canis Minor and Canis Major 2025 GRATs and family trust LLCs. Remaining Class B shares held by these entities are convertible into Class A Common Stock on a one-for-one basis.